ASML vs CUE · P/E 57, $665.37B cap vs rev $9.3M
ASML Holding NV ADR (ASML) versus Cue Biopharma (CUE) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Cue Biopharma (CUE) is a biotechnology company listed on US.
ASML does not have a complete income-statement cache yet.
Latest reported CUE revenue for 2024-12-31 was $9.3M. Net income was -$40.7M. Revenue was up 69.2% from 2023-12-31 to 2024-12-31. CUE currently screens at market cap $59.5M.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. CUE currently screens at market cap $59.5M.
Not investment advice. Open the ASML and CUE stock pages for the full models.
Not investment advice.